| DNA binding of the glucocorticoid receptor is not essential for survival HM Reichardt, KH Kaestner, J Tuckermann, O Kretz, O Wessely, R Bock, ... Cell 93 (4), 531-541, 1998 | 1359 | 1998 |
| Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor HM Reichardt, JP Tuckermann, M Göttlicher, M Vujic, F Weih, P Angel, ... The EMBO journal 20 (24), 7168-7173, 2001 | 564 | 2001 |
| Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1 SM Abraham, T Lawrence, A Kleiman, P Warden, M Medghalchi, ... The Journal of experimental medicine 203 (8), 1883-1889, 2006 | 484 | 2006 |
| Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor A Rauch, S Seitz, U Baschant, AF Schilling, A Illing, B Stride, M Kirilov, ... Cell metabolism 11 (6), 517-531, 2010 | 440 | 2010 |
| The role of the glucocorticoid receptor in inflammation and immunity U Baschant, J Tuckermann The Journal of steroid biochemistry and molecular biology 120 (2-3), 69-75, 2010 | 436 | 2010 |
| Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures S Movérare-Skrtic, P Henning, X Liu, K Nagano, H Saito, AE Börjesson, ... Nature medicine 20 (11), 1279-1288, 2014 | 353 | 2014 |
| New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation S Vandevyver, L Dejager, J Tuckermann, C Libert Endocrinology 154 (3), 993-1007, 2013 | 340 | 2013 |
| Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy JP Tuckermann, A Kleiman, R Moriggl, R Spanbroek, A Neumann, A Illing, ... The Journal of clinical investigation 117 (5), 1381-1390, 2007 | 314 | 2007 |
| The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism JP Labrador, V Azcoitia, J Tuckermann, C Lin, E Olaso, S Mañes, ... EMBO reports 2 (5), 446-452, 2001 | 295 | 2001 |
| Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids FP Limbourg, Z Huang, JC Plumier, T Simoncini, M Fujioka, ... The Journal of clinical investigation 110 (11), 1729-1738, 2002 | 266 | 2002 |
| Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis JP Tuckermann, A Kleiman, KG McPherson, HM Reichardt Critical reviews in clinical laboratory sciences 42 (1), 71-104, 2005 | 251 | 2005 |
| Molecular actions of glucocorticoids in cartilage and bone during health, disease, and steroid therapy K Hartmann, M Koenen, S Schauer, S Wittig-Blaich, M Ahmad, ... Physiological reviews 96 (2), 409-447, 2016 | 237 | 2016 |
| The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1–dependent genes in skin JP Tuckermann, HM Reichardt, R Arribas, KH Richter, G Schütz, P Angel The Journal of cell biology 147 (7), 1365-1370, 1999 | 233 | 1999 |
| Increased skeletal VEGF enhances β‐catenin activity and results in excessively ossified bones C Maes, S Goossens, S Bartunkova, B Drogat, L Coenegrachts, ... The EMBO journal 29 (2), 424-441, 2010 | 221 | 2010 |
| Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis S Wust, J van den Brandt, D Tischner, A Kleiman, JP Tuckermann, R Gold, ... The Journal of Immunology 180 (12), 8434-8443, 2008 | 202 | 2008 |
| Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice A Kleiman, JP Tuckermann Molecular and cellular endocrinology 275 (1-2), 98-108, 2007 | 196 | 2007 |
| Inflammatory monocytes and Fcγ receptor IV on osteoclasts are critical for bone destruction during inflammatory arthritis in mice M Seeling, U Hillenhoff, JP David, G Schett, J Tuckermann, A Lux, ... Proceedings of the National Academy of Sciences 110 (26), 10729-10734, 2013 | 187 | 2013 |
| Liver cancer initiation requires p53 inhibition by CD44-enhanced growth factor signaling D Dhar, L Antonucci, H Nakagawa, JY Kim, E Glitzner, S Caruso, ... Cancer cell 33 (6), 1061-1077. e6, 2018 | 182 | 2018 |
| Chemical hybridization of glucagon and thyroid hormone optimizes therapeutic impact for metabolic disease B Finan, C Clemmensen, Z Zhu, K Stemmer, K Gauthier, L Müller, ... Cell 167 (3), 843-857. e14, 2016 | 182 | 2016 |
| Genomic redistribution of GR monomers and dimers mediates transcriptional response to exogenous glucocorticoid in vivo HW Lim, NH Uhlenhaut, A Rauch, J Weiner, S Hübner, N Hübner, KJ Won, ... Genome research 25 (6), 836-844, 2015 | 179 | 2015 |
